Comparative Outcomes of Consolidation Strategies After R-MVP Induction in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.

Among the 52 patients in each group matched for age, ECOG PS, and treatment response to R‐MVP, median PFS was not reached in the ASCT group and was 90.0 months (95% CI 41.0–NR) in the WBRT one, but the difference did not reach statistical significance ( p = 0.050, Figure 2A ).

also in 59,377 other papers

In the PSM analysis comparing ASCT and WBRT, ASCT showed a trend toward superior PFS (median not reached vs. 90.0 months, p = 0.050), although OS differences did not reach statistical significance (median not reached vs. 97.9 months, p = 0.160).

also in 26,766 other papers